nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—Paget's disease of bone—sarcoma	0.886	1	CtDrD
Tiludronate—PTPN1—myometrium—sarcoma	0.00384	0.0723	CbGeAlD
Tiludronate—PTPN1—embryo—sarcoma	0.00369	0.0696	CbGeAlD
Tiludronate—PTPN1—seminal vesicle—sarcoma	0.00347	0.0653	CbGeAlD
Tiludronate—PTPN1—hematopoietic system—sarcoma	0.0033	0.0621	CbGeAlD
Tiludronate—ATP6V1A—mammary gland—sarcoma	0.00324	0.0611	CbGeAlD
Tiludronate—PTPN1—connective tissue—sarcoma	0.00318	0.0598	CbGeAlD
Tiludronate—PTPN1—N-cadherin signaling events—PLCG1—sarcoma	0.00293	0.0536	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—IGF1R—sarcoma	0.00253	0.0462	CbGpPWpGaD
Tiludronate—PTPN1—cardiac atrium—sarcoma	0.0025	0.0472	CbGeAlD
Tiludronate—PTPN1—uterus—sarcoma	0.00249	0.0469	CbGeAlD
Tiludronate—PTPN1—lymphoid tissue—sarcoma	0.00232	0.0437	CbGeAlD
Tiludronate—ATP6V1A—myometrium—sarcoma	0.0023	0.0433	CbGeAlD
Tiludronate—ATP6V1A—embryo—sarcoma	0.00221	0.0417	CbGeAlD
Tiludronate—PTPN1—tendon—sarcoma	0.00218	0.0411	CbGeAlD
Tiludronate—ATP6V1A—hematopoietic system—sarcoma	0.00198	0.0372	CbGeAlD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—PDGFRB—sarcoma	0.00191	0.0349	CbGpPWpGaD
Tiludronate—PTPN1—testis—sarcoma	0.00181	0.034	CbGeAlD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—IGF1R—sarcoma	0.00173	0.0317	CbGpPWpGaD
Tiludronate—ATP6V1A—skin of body—sarcoma	0.00172	0.0323	CbGeAlD
Tiludronate—PTPN1—liver—sarcoma	0.00171	0.0322	CbGeAlD
Tiludronate—PTPN1—Leptin signaling pathway—PLCG1—sarcoma	0.00163	0.0298	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—KDR—sarcoma	0.00158	0.0289	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PLCG1—sarcoma	0.00155	0.0283	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—PDGFRB—sarcoma	0.00155	0.0283	CbGpPWpGaD
Tiludronate—ATP6V1A—cardiac atrium—sarcoma	0.0015	0.0283	CbGeAlD
Tiludronate—ATP6V1A—uterus—sarcoma	0.00149	0.0281	CbGeAlD
Tiludronate—ATP6V1A—lymphoid tissue—sarcoma	0.00139	0.0262	CbGeAlD
Tiludronate—PTPN1—lymph node—sarcoma	0.00131	0.0247	CbGeAlD
Tiludronate—ATP6V1A—tendon—sarcoma	0.00131	0.0246	CbGeAlD
Tiludronate—ATP6V1A—bone marrow—sarcoma	0.00127	0.0239	CbGeAlD
Tiludronate—PTPN1—Integrin alphaIIb beta3 signaling—SRC—sarcoma	0.00122	0.0224	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—FOXO1—sarcoma	0.00115	0.0211	CbGpPWpGaD
Tiludronate—ATP6V1A—testis—sarcoma	0.00108	0.0204	CbGeAlD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PLCG1—sarcoma	0.00108	0.0198	CbGpPWpGaD
Tiludronate—PTPN1—N-cadherin signaling events—CTNNB1—sarcoma	0.00108	0.0197	CbGpPWpGaD
Tiludronate—ATP6V1A—liver—sarcoma	0.00102	0.0193	CbGeAlD
Tiludronate—PTPN1—Platelet Aggregation (Plug Formation)—SRC—sarcoma	0.000951	0.0174	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—SRC—sarcoma	0.000893	0.0163	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000873	0.016	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—VEGFA—sarcoma	0.00087	0.0159	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—sarcoma	0.000857	0.0157	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—sarcoma	0.000854	0.0156	CbGpPWpGaD
Tiludronate—PTPN1—Interferon Signaling—PLCG1—sarcoma	0.00085	0.0155	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—CREB1—sarcoma	0.000838	0.0153	CbGpPWpGaD
Tiludronate—PTPN1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—sarcoma	0.000833	0.0152	CbGpPWpGaD
Tiludronate—PTPN1—IGF1 pathway—HRAS—sarcoma	0.000792	0.0145	CbGpPWpGaD
Tiludronate—ATP6V1A—lymph node—sarcoma	0.000785	0.0148	CbGeAlD
Tiludronate—PTPN1—Signaling events mediated by TCPTP—EGFR—sarcoma	0.000783	0.0143	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—SRC—sarcoma	0.000772	0.0141	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PDGFRB—sarcoma	0.000766	0.014	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—SRC—sarcoma	0.000724	0.0133	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—sarcoma	0.000677	0.0124	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—IGF1R—sarcoma	0.000662	0.0121	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by PTP1B—EGFR—sarcoma	0.000635	0.0116	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—FOXO1—sarcoma	0.00063	0.0115	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TEK—sarcoma	0.000613	0.0112	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—CCND1—sarcoma	0.000604	0.011	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Pathway—HRAS—sarcoma	0.000572	0.0105	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—JUN—sarcoma	0.000572	0.0105	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—sarcoma	0.000568	0.0104	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PLCG1—sarcoma	0.000567	0.0104	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—ANGPT2—sarcoma	0.00056	0.0103	CbGpPWpGaD
Tiludronate—PTPN1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—sarcoma	0.000543	0.00994	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—SRC—sarcoma	0.00054	0.00989	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—SRC—sarcoma	0.000513	0.00939	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFC—sarcoma	0.00045	0.00823	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—JUN—sarcoma	0.0004	0.00733	CbGpPWpGaD
Tiludronate—PTPN1—Leptin signaling pathway—HRAS—sarcoma	0.00038	0.00696	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—NRAS—sarcoma	0.000367	0.00671	CbGpPWpGaD
Tiludronate—PTPN1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—sarcoma	0.000361	0.00661	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—SRC—sarcoma	0.000359	0.00657	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLCG1—sarcoma	0.000353	0.00647	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—NRAS—sarcoma	0.000345	0.00632	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—JUN—sarcoma	0.000329	0.00601	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MYC—sarcoma	0.000322	0.00589	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—KRAS—sarcoma	0.000316	0.00578	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—KRAS—sarcoma	0.000297	0.00544	CbGpPWpGaD
Tiludronate—Bone pain—Vincristine—sarcoma	0.00028	0.0421	CcSEcCtD
Tiludronate—Bone pain—Mitoxantrone—sarcoma	0.000272	0.041	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—HRAS—sarcoma	0.000268	0.00491	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CD34—sarcoma	0.000262	0.00479	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—IL2—sarcoma	0.000261	0.00477	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—TLE1—sarcoma	0.000258	0.00472	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—HRAS—sarcoma	0.000253	0.00462	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NPM1—sarcoma	0.000233	0.00426	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SRC—sarcoma	0.000228	0.00417	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.000222	0.00406	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL2—sarcoma	0.000216	0.00395	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—HRAS—sarcoma	0.000207	0.0038	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ENO2—sarcoma	0.000202	0.00369	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PTPRC—sarcoma	0.000189	0.00347	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PLCG1—sarcoma	0.000185	0.00339	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—NRAS—sarcoma	0.000181	0.00332	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TLE1—sarcoma	0.000181	0.00331	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TLE1—sarcoma	0.000181	0.00331	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ATF1—sarcoma	0.000176	0.00322	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PLCG1—sarcoma	0.000171	0.00313	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CXCR4—sarcoma	0.000164	0.00301	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—KRAS—sarcoma	0.000156	0.00285	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFC—sarcoma	0.000152	0.00279	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFC—sarcoma	0.000152	0.00279	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—IL2—sarcoma	0.000134	0.00246	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HRAS—sarcoma	0.000133	0.00243	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FOXO1—sarcoma	0.000131	0.00241	CbGpPWpGaD
Tiludronate—Rhinitis—Mitoxantrone—sarcoma	0.000131	0.0198	CcSEcCtD
Tiludronate—PTPN1—Immune System—PDGFRB—sarcoma	0.000131	0.0024	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PDGFRA—sarcoma	0.000129	0.00236	CbGpPWpGaD
Tiludronate—Back pain—Thiotepa—sarcoma	0.000128	0.0192	CcSEcCtD
Tiludronate—Bone pain—Epirubicin—sarcoma	0.000127	0.0191	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—FLT1—sarcoma	0.000122	0.00223	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FLT1—sarcoma	0.000122	0.00223	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FOXO1—sarcoma	0.000121	0.00222	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PDGFRB—sarcoma	0.000121	0.00222	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PLCG1—sarcoma	0.00012	0.00219	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PLCG1—sarcoma	0.00012	0.00219	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PDGFRA—sarcoma	0.000119	0.00218	CbGpPWpGaD
Tiludronate—Influenza like illness—Epirubicin—sarcoma	0.000118	0.0178	CcSEcCtD
Tiludronate—Bone pain—Doxorubicin—sarcoma	0.000118	0.0177	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—SRC—sarcoma	0.000117	0.00215	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCR4—sarcoma	0.000115	0.00211	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCR4—sarcoma	0.000115	0.00211	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—sarcoma	0.000114	0.00209	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ATF1—sarcoma	0.000114	0.00208	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ATF1—sarcoma	0.000114	0.00208	CbGpPWpGaD
Tiludronate—Back pain—Vincristine—sarcoma	0.000113	0.0171	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—NRAS—sarcoma	0.000113	0.00207	CbGpPWpGaD
Tiludronate—Arthralgia—Thiotepa—sarcoma	0.000112	0.0169	CcSEcCtD
Tiludronate—Myalgia—Thiotepa—sarcoma	0.000112	0.0169	CcSEcCtD
Tiludronate—Myalgia—Dactinomycin—sarcoma	0.000112	0.0168	CcSEcCtD
Tiludronate—Back pain—Mitoxantrone—sarcoma	0.00011	0.0166	CcSEcCtD
Tiludronate—Influenza like illness—Doxorubicin—sarcoma	0.000109	0.0165	CcSEcCtD
Tiludronate—Vertigo—Vincristine—sarcoma	0.000105	0.0158	CcSEcCtD
Tiludronate—PTPN1—Immune System—KIT—sarcoma	0.0001	0.00183	CbGpPWpGaD
Tiludronate—Myalgia—Vincristine—sarcoma	9.98e-05	0.015	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Thiotepa—sarcoma	9.83e-05	0.0148	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Dactinomycin—sarcoma	9.75e-05	0.0147	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—KRAS—sarcoma	9.72e-05	0.00178	CbGpPWpGaD
Tiludronate—Arthralgia—Mitoxantrone—sarcoma	9.71e-05	0.0146	CcSEcCtD
Tiludronate—Myalgia—Mitoxantrone—sarcoma	9.71e-05	0.0146	CcSEcCtD
Tiludronate—PTPN1—Immune System—CREB1—sarcoma	9.54e-05	0.00175	CbGpPWpGaD
Tiludronate—Dyspepsia—Thiotepa—sarcoma	9.49e-05	0.0143	CcSEcCtD
Tiludronate—ATP6V1A—Disease—KIT—sarcoma	9.25e-05	0.00169	CbGpPWpGaD
Tiludronate—Pain—Thiotepa—sarcoma	9.22e-05	0.0139	CcSEcCtD
Tiludronate—Back pain—Etoposide—sarcoma	9.18e-05	0.0138	CcSEcCtD
Tiludronate—Pain—Dactinomycin—sarcoma	9.15e-05	0.0138	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—IGF1R—sarcoma	8.93e-05	0.00163	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IGF1R—sarcoma	8.93e-05	0.00163	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Thiotepa—sarcoma	8.82e-05	0.0133	CcSEcCtD
Tiludronate—ATP6V1A—Disease—CREB1—sarcoma	8.81e-05	0.00161	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Dactinomycin—sarcoma	8.75e-05	0.0132	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Vincristine—sarcoma	8.71e-05	0.0131	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—TP53—sarcoma	8.63e-05	0.00158	CbGpPWpGaD
Tiludronate—Vertigo—Etoposide—sarcoma	8.53e-05	0.0128	CcSEcCtD
Tiludronate—Abdominal pain—Thiotepa—sarcoma	8.53e-05	0.0128	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—FOXO1—sarcoma	8.5e-05	0.00156	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FOXO1—sarcoma	8.5e-05	0.00156	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFRB—sarcoma	8.49e-05	0.00155	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFRB—sarcoma	8.49e-05	0.00155	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Mitoxantrone—sarcoma	8.48e-05	0.0128	CcSEcCtD
Tiludronate—Abdominal pain—Dactinomycin—sarcoma	8.46e-05	0.0127	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—PDGFRA—sarcoma	8.35e-05	0.00153	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PDGFRA—sarcoma	8.35e-05	0.00153	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HRAS—sarcoma	8.26e-05	0.00151	CbGpPWpGaD
Tiludronate—Dyspepsia—Mitoxantrone—sarcoma	8.2e-05	0.0123	CcSEcCtD
Tiludronate—Pain—Vincristine—sarcoma	8.18e-05	0.0123	CcSEcCtD
Tiludronate—Pain—Mitoxantrone—sarcoma	7.96e-05	0.012	CcSEcCtD
Tiludronate—PTPN1—Immune System—MDM2—sarcoma	7.89e-05	0.00144	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Vincristine—sarcoma	7.82e-05	0.0118	CcSEcCtD
Tiludronate—Asthenia—Thiotepa—sarcoma	7.74e-05	0.0116	CcSEcCtD
Tiludronate—Asthenia—Dactinomycin—sarcoma	7.68e-05	0.0116	CcSEcCtD
Tiludronate—Gastrointestinal pain—Mitoxantrone—sarcoma	7.62e-05	0.0115	CcSEcCtD
Tiludronate—Abdominal pain—Vincristine—sarcoma	7.56e-05	0.0114	CcSEcCtD
Tiludronate—Diarrhoea—Thiotepa—sarcoma	7.38e-05	0.0111	CcSEcCtD
Tiludronate—Abdominal pain—Mitoxantrone—sarcoma	7.36e-05	0.0111	CcSEcCtD
Tiludronate—Diarrhoea—Dactinomycin—sarcoma	7.32e-05	0.011	CcSEcCtD
Tiludronate—ATP6V1A—Disease—MDM2—sarcoma	7.29e-05	0.00133	CbGpPWpGaD
Tiludronate—Dizziness—Thiotepa—sarcoma	7.13e-05	0.0107	CcSEcCtD
Tiludronate—PTPN1—Immune System—IL2—sarcoma	7.05e-05	0.00129	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KDR—sarcoma	7.03e-05	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KDR—sarcoma	7.03e-05	0.00129	CbGpPWpGaD
Tiludronate—Asthenia—Vincristine—sarcoma	6.86e-05	0.0103	CcSEcCtD
Tiludronate—PTPN1—Immune System—JUN—sarcoma	6.86e-05	0.00126	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTNNB1—sarcoma	6.81e-05	0.00125	CbGpPWpGaD
Tiludronate—Headache—Thiotepa—sarcoma	6.76e-05	0.0102	CcSEcCtD
Tiludronate—Asthenia—Mitoxantrone—sarcoma	6.68e-05	0.0101	CcSEcCtD
Tiludronate—Pain—Etoposide—sarcoma	6.62e-05	0.00997	CcSEcCtD
Tiludronate—Diarrhoea—Vincristine—sarcoma	6.54e-05	0.00985	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—KIT—sarcoma	6.48e-05	0.00119	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KIT—sarcoma	6.48e-05	0.00119	CbGpPWpGaD
Tiludronate—Nausea—Thiotepa—sarcoma	6.41e-05	0.00964	CcSEcCtD
Tiludronate—Diarrhoea—Mitoxantrone—sarcoma	6.37e-05	0.00959	CcSEcCtD
Tiludronate—Nausea—Dactinomycin—sarcoma	6.36e-05	0.00957	CcSEcCtD
Tiludronate—Gastrointestinal pain—Etoposide—sarcoma	6.33e-05	0.00953	CcSEcCtD
Tiludronate—Dizziness—Vincristine—sarcoma	6.32e-05	0.00952	CcSEcCtD
Tiludronate—ATP6V1A—Disease—CTNNB1—sarcoma	6.28e-05	0.00115	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CREB1—sarcoma	6.17e-05	0.00113	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CREB1—sarcoma	6.17e-05	0.00113	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—SRC—sarcoma	6.15e-05	0.00113	CbGpPWpGaD
Tiludronate—Rhinitis—Epirubicin—sarcoma	6.13e-05	0.00922	CcSEcCtD
Tiludronate—Abdominal pain—Etoposide—sarcoma	6.12e-05	0.00922	CcSEcCtD
Tiludronate—Headache—Vincristine—sarcoma	5.99e-05	0.00902	CcSEcCtD
Tiludronate—PTPN1—Immune System—NRAS—sarcoma	5.92e-05	0.00108	CbGpPWpGaD
Tiludronate—Headache—Mitoxantrone—sarcoma	5.83e-05	0.00878	CcSEcCtD
Tiludronate—ATP6V1A—Disease—SRC—sarcoma	5.68e-05	0.00104	CbGpPWpGaD
Tiludronate—Nausea—Vincristine—sarcoma	5.68e-05	0.00855	CcSEcCtD
Tiludronate—Rhinitis—Doxorubicin—sarcoma	5.67e-05	0.00853	CcSEcCtD
Tiludronate—Asthenia—Etoposide—sarcoma	5.56e-05	0.00837	CcSEcCtD
Tiludronate—Nausea—Mitoxantrone—sarcoma	5.53e-05	0.00833	CcSEcCtD
Tiludronate—ATP6V1A—Disease—NRAS—sarcoma	5.46e-05	0.001	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—sarcoma	5.39e-05	0.000987	CbGpPWpGaD
Tiludronate—Diarrhoea—Etoposide—sarcoma	5.3e-05	0.00798	CcSEcCtD
Tiludronate—Back pain—Epirubicin—sarcoma	5.15e-05	0.00775	CcSEcCtD
Tiludronate—Dizziness—Etoposide—sarcoma	5.12e-05	0.00771	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—MDM2—sarcoma	5.1e-05	0.000934	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MDM2—sarcoma	5.1e-05	0.000934	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—sarcoma	5.09e-05	0.000932	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—sarcoma	5.09e-05	0.000931	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—sarcoma	4.98e-05	0.000911	CbGpPWpGaD
Tiludronate—Headache—Etoposide—sarcoma	4.85e-05	0.0073	CcSEcCtD
Tiludronate—Vertigo—Epirubicin—sarcoma	4.78e-05	0.00719	CcSEcCtD
Tiludronate—Back pain—Doxorubicin—sarcoma	4.76e-05	0.00717	CcSEcCtD
Tiludronate—ATP6V1A—Disease—KRAS—sarcoma	4.7e-05	0.000861	CbGpPWpGaD
Tiludronate—Nausea—Etoposide—sarcoma	4.6e-05	0.00693	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—IL2—sarcoma	4.56e-05	0.000834	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL2—sarcoma	4.56e-05	0.000834	CbGpPWpGaD
Tiludronate—Arthralgia—Epirubicin—sarcoma	4.53e-05	0.00682	CcSEcCtD
Tiludronate—Myalgia—Epirubicin—sarcoma	4.53e-05	0.00682	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—sarcoma	4.44e-05	0.000813	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—sarcoma	4.44e-05	0.000813	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JUN—sarcoma	4.43e-05	0.000811	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JUN—sarcoma	4.43e-05	0.000811	CbGpPWpGaD
Tiludronate—Vertigo—Doxorubicin—sarcoma	4.42e-05	0.00666	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—CTNNB1—sarcoma	4.4e-05	0.000805	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CTNNB1—sarcoma	4.4e-05	0.000805	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—sarcoma	4.33e-05	0.000792	CbGpPWpGaD
Tiludronate—Arthralgia—Doxorubicin—sarcoma	4.19e-05	0.00631	CcSEcCtD
Tiludronate—Myalgia—Doxorubicin—sarcoma	4.19e-05	0.00631	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HRAS—sarcoma	4e-05	0.000732	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SRC—sarcoma	3.98e-05	0.000728	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SRC—sarcoma	3.98e-05	0.000728	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Epirubicin—sarcoma	3.96e-05	0.00595	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—sarcoma	3.87e-05	0.000709	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—sarcoma	3.87e-05	0.000709	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NRAS—sarcoma	3.83e-05	0.0007	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NRAS—sarcoma	3.83e-05	0.0007	CbGpPWpGaD
Tiludronate—Dyspepsia—Epirubicin—sarcoma	3.82e-05	0.00575	CcSEcCtD
Tiludronate—Pain—Epirubicin—sarcoma	3.71e-05	0.00559	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Doxorubicin—sarcoma	3.66e-05	0.00551	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—sarcoma	3.56e-05	0.000652	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—sarcoma	3.56e-05	0.000652	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Epirubicin—sarcoma	3.55e-05	0.00534	CcSEcCtD
Tiludronate—Dyspepsia—Doxorubicin—sarcoma	3.54e-05	0.00532	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—sarcoma	3.49e-05	0.000638	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—sarcoma	3.49e-05	0.000638	CbGpPWpGaD
Tiludronate—Pain—Doxorubicin—sarcoma	3.44e-05	0.00517	CcSEcCtD
Tiludronate—Abdominal pain—Epirubicin—sarcoma	3.43e-05	0.00517	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—sarcoma	3.29e-05	0.000603	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—sarcoma	3.29e-05	0.000603	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Doxorubicin—sarcoma	3.29e-05	0.00494	CcSEcCtD
Tiludronate—Abdominal pain—Doxorubicin—sarcoma	3.18e-05	0.00478	CcSEcCtD
Tiludronate—Asthenia—Epirubicin—sarcoma	3.12e-05	0.00469	CcSEcCtD
Tiludronate—Diarrhoea—Epirubicin—sarcoma	2.97e-05	0.00447	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—sarcoma	2.93e-05	0.000536	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—sarcoma	2.93e-05	0.000536	CbGpPWpGaD
Tiludronate—Asthenia—Doxorubicin—sarcoma	2.88e-05	0.00434	CcSEcCtD
Tiludronate—Dizziness—Epirubicin—sarcoma	2.87e-05	0.00432	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—sarcoma	2.8e-05	0.000512	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—sarcoma	2.8e-05	0.000512	CbGpPWpGaD
Tiludronate—Diarrhoea—Doxorubicin—sarcoma	2.75e-05	0.00414	CcSEcCtD
Tiludronate—Headache—Epirubicin—sarcoma	2.72e-05	0.00409	CcSEcCtD
Tiludronate—Dizziness—Doxorubicin—sarcoma	2.66e-05	0.004	CcSEcCtD
Tiludronate—Nausea—Epirubicin—sarcoma	2.58e-05	0.00388	CcSEcCtD
Tiludronate—Headache—Doxorubicin—sarcoma	2.52e-05	0.00379	CcSEcCtD
Tiludronate—Nausea—Doxorubicin—sarcoma	2.39e-05	0.00359	CcSEcCtD
